The oviduct produces erythropoietin in an estrogen- and oxygen-dependent manner

American Journal of Physiology - Endocrinology and Metabolism

Volumn 278, Issue 6 41-6, 2000, Pages

  Masuda, Seiji ^a   Kobayashi, Toshihiro ^a   Chikuma, Mariko ^a   Nagao, Masaya ^a   Sasaki, Ryuzo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Hypoxia; ICI 182780; Isthmus; Ovary; Tamoxifen

Indexed keywords

ERYTHROPOIETIN; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA; OXYGEN; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOWN REGULATION; FEMALE; FERTILIZATION; HYPOXIA; MOUSE; NONHUMAN; OVARY; OVIDUCT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TISSUE SPECIFICITY;

EID: 0033936178     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2000.278.6.e1038     Document Type: Article

References (50)

1. Anagnostou A, Lee ES, Kessimian N, Levinson R, and Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 87: 5978-5982, 1990.
2. Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, and Noguchi CT. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 91: 3974-3978, 1994.
3. Assandri R, Egger M, Gassmann M, Niggli E, Bauer C, Forster I, and Gorlach A. Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line. J Physiol (Lond) 516: 343-352, 1999.
4. Barrett TJ and Spelsberg TC. Steroid receptors at the nexus of transcriptional regulation. J Cell Biochem Suppl 30-31: 185-193, 1998.
5. Bunn HF and Poyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 76: 839-885, 1996.
6. Carlini RG, Reyes AA, and Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 47: 740-745, 1995.
7. Chen JD and Li H. Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors. Crit Rev Eukaryot Gene Expr 8: 169-190, 1998.
8. Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, and Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 92: 3717-3720, 1995.
9. Fan S, Wang J-A, Yuan R, Ma R, Meng Q, Edros MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID, and Rosen EM. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284: 1354-1356, 1999.
10. Fandrey J, Pagel H, Frede S, Wolff M, and Jelkmann W. Thyroid hormones enhance hypoxia-induced erythropoietin in vitro. Exp Hematol 22: 272-277, 1994.
11. Gallo MA and Kaufman D. Antagonistic and agonistic effects of tamoxifen: significance in human cancer. Semin Oncol 24, Suppl 1: 71-81, 1997.
12. Gibson MK, Nemmers LA, Beckman WC Jr, Davis VL, Curtis SW, and Korach KS. The mechanism of ICI 164, 384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. Endocrinology 129: 2000-2010, 1991.
13. Goto M, Akai K, Murakami A, Hashimoto C, Tsuda E, Ueda M, Kawanishi G, Takahashi N, Ishimoto A, Chiba H, and Sasaki R. Production of recombinant human erythropoietin in mammalian cells: host-cell dependency of the biological activity of the cloned glycoprotein. Biol Technology 6: 67-71, 1988.
14. Goto M, Murakami A, Akai K, Kawanishi G, Ueda M, Chiba H, and Sasaki R. Characterization and use of monoclonal antibodies directed against human erythropoietin that recognize different antigenic determinants. Blood 74: 1415-1423, 1989.
15. Guillemin K and Krasnow MA. The hypoxic response: huffing and hifing. Cell 89: 9-12, 1997.
16. Haller H, Christel C, Dannenberg L, Thiele P, Lindschau C, and Luft FC. Signal transduction of erythropoietin in endothelial cells. Kidney Int 50: 481-488, 1996.
17. Heid CA, Stevens J, Livak KJ, and Williams PM. Real time quantitative PCR. Genome Res 6: 986-994, 1996.
18. Horigome T, Ogata F, Golding TS, and Korach KS. Estradiol-stimulated proteolytic cleavage of the estrogen receptor in mouse uterus. Endocrinology 123: 2540-2548, 1988.
19. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 72: 449-489, 1992.
20. Jenster G. Coactivators and corepressors as mediators of nuclear receptor function: an update. Mol Cell Endocrinol 143: 1-7, 1998.
21. Kato S, Tora L, Yamaguchi J, Masushige S, Bellard M, and Chambon P. A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5'-TGACC-3' motifs acting synergistically. Cell 68: 731-742, 1992.
22. Klein-Hitpass L, Schwerk C, Kahmann S, and Vassen L. Targets of activated steroid hormone receptors: basal transcription factors and receptor interacting proteins. J Mol Med 76: 490-496, 1998.
23. Krantz SB. Erythropoietin. Blood 77: 419-434, 1991.
24. Lin C-S, Lim S-K, D'Agati V, and Costantini F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev 10: 154-164, 1996.
25. Liu C, Shen K, Liu Z, and Noguchi CT. Regulated human erythropoietin receptor expression in mouse brain. J Biol Chem 272: 32395-32400, 1997.
26. Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, Yonekawa Y, Bauer C, and Gassmann M. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 8: 666-676, 1996.
27. Masuda S, Chikuma M, and Sasaki R. Insulin-like growth factors and insulin stimulate erythropoietin production in primary cultured astrocytes. Brain Res 746: 63-70, 1997.
28. Masuda S, Nagao M, and Sasaki R. Erythropoietic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin production. Int J Hematol 70: 1-6, 1999.
29. Masuda S, Nagao M, Takahata K, Konishi Y, Gallyas F Jr, Tabira T, and Sasaki R. Functional erythropoietin receptor of the cells with neural characteristics: comparison with receptor properties of erythroid cells. J Biol Chem 268: 11208-11216, 1993.
30. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, and Sasaki R. A novel site of erythropoietin production: oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269: 19488-19493, 1994.
31. Maxwell PH, Wiesener MS, G Chang-W, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, and Ratcliffe PJ. The tumor suppressor protein VHL targets for oxygen-dependent proteolysis. Nature 399: 271-275, 1999.
32. Morishita E, Masuda S, Nagao M, Yasuda Y, and Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76: 105-116, 1997.
33. Okano M, Masuda S, Narita H, Masushige S, Kato S, Imagawa S, and Sasaki R. Retinoic acid up-regulates erythropoietin production in hepatoma cells and in vitamin A-depleted rats. FEBS Lett 349: 229-233, 1994.
34. Parker MG. Transcriptional activation by oestrogen receptors. Biochem Soc Symp 63: 45-50, 1998.
35. Pink JJ and Jordan VC. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res 56: 2321-2330, 1996.
36. Porter DL and Goldberg MA. Regulation of erythropoietin production. Exp Hematol 21: 399-404, 1993.
37. Ratcliffe PJ, O'Rourke JF, Maxwell PH, and Pugh CW. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 201: 1153-1162, 1998.
38. Sadamoto Y, Igase K, Sakanaka M, Sato K, Otsuka H, Sakaki S, Masuda S, and Sasaki R. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 253: 26-32, 1998.
39. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, and Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 95: 4635-4640, 1998.
40. Semenza GL. Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis. J Lab Clin Med 131: 207-214, 1998.
41. Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ, and O'Malley BW. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 52: 141-164, 1997.
42. Shoemaker CB and Mitsock LD. Murine erythropoietin gene: cloning, expression, and human gene homology. Mol Cell Biol 6: 849-858, 1986.
43. Tan CC, Eckardt K-U, Firth JD, and Ratcliffe PJ. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol Renal Fluid Electrolyte Physiol 263: F474-F481, 1992.
44. Torchia J, Glass C, and Rosenfeld MG. Co-activators and co-repressors in the integration of transcriptional responses. Curr Opin Cell Biol 10: 373-383, 1998.
45. Wenger RH and Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 378: 609-616, 1997.
46. Wu H, Liu X, Jaenisch R, and Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83: 59-67, 1995.
47. Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miyatake K, and Nakano Y. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem 239: 494-500, 1996.
48. Yamamoto Y, Sofikitis N, and Miyagawa I. Effects of erythropoietin, bromocryptine and hydrazine on testicular function in rats with chronic renal failure. Andrologia 29: 141-144, 1997.
49. Yasuda Y, Masuda S, Chikuma M, Inoue K, Nagao M, and Sasaki R. Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J Biol Chem 273: 25381-25387, 1998.
50. Youssoufian H, Longmore G, Neumann D, Yoshimura A, and Lodish HF. Structure, function, and activation of the erythropoietin receptor. Blood 81: 2223-2236, 1993.